ChemMedChem

Papers
(The H4-Index of ChemMedChem is 28. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Late‐Stage Diversification of Pyrazoles as Antileishmanial Agents167
97
Nicorandil Repurposing in Orofacial Pain: Preclinical Findings in Adult Zebrafish89
88
Front Cover: Design Principles for Balancing Lipophilicity and Permeability in beyond Rule of 5 Space (ChemMedChem 5/2024) (ChemMedChem 5/2024)86
Scouting Different Phosphodiesterase 4 Inhibitor Chemotypes in Silico To Guide the Design of Anti‐inflammatory/Antioxidant Agents67
63
Anti‐Sporothrix Activity of Novel Copper‐Itraconazole Complexes57
Front Cover: (ChemMedChem 12/2025)54
An Active Member of the EFMC: The Division of Medicinal Chemistry and Chemical Biology of the Swiss Chemical Society**52
Insights into the Overcoming EGFRDel19/T790M/C797S Mutation: A Perspective on the 2‐Aryl‐4‐aminothienopyrimidine Backbone49
Optimization of Ketobenzothiazole‐Based Type II Transmembrane Serine Protease Inhibitors to Block H1N1 Influenza Virus Replication48
C9‐Functionalized Doxycycline Analogs as Drug Candidates to Prevent Pathological α‐Synuclein Aggregation and Neuroinflammation in Parkinson's Disease Degeneration42
Phosphate‐Containing Glycolipids: A Review on Synthesis and Bioactivity42
Fluorescence‐Based Detection of Methionine for Noninvasive Cancer Diagnosis Using Cu–Sn Bimetallic Nanoclusters41
“Cofactors” for Natural Products38
The 5′ Cap Epitranscriptome and Beyond: Natural and Engineered 5′ Cap Modifications for Optimizing mRNA Therapeutics and Functional Studies37
Metalloids: Semi as Metals yet Full of Antimicrobial Potential36
Therapeutic Exosomes for Rare Cancers: Advances and Clinical Translation35
Front Cover: Functional Proteomics of Quinazolin‐4‐One Derivatives Targeting the Proteasome (ChemMedChem 2/2026)34
Redox Disruption Induced by Saquayamycin B1 Promotes Cytotoxicity in Resistant Melanoma Cells33
Importance of Co‐operative Hydrogen Bonding in the Apramycin‐Ribosomal Decoding A‐Site Interaction32
Incorporation of Trifluoromethyltriazoline in the Side Chain of 4‐Aminoquinolines: Synthesis and Evaluation as Antiplasmodial Agents31
Quantum Osteoimmunology: A Paradigm Shift in Understanding and Influencing Bone–Immune Crosstalk31
Chemical Design Strategy of Ionizable Lipids for In Vivo mRNA Delivery31
Designing Cyclic Nitrogen‐Bridged Sulfonamides with Anti‐Cancer Activity29
Design and Synthesis of 1,3‐Diynes as Potent Antifungal Agents against Aspergillus fumigatus29
Hepatic‐Targeted Nano‐enzyme with Resveratrol Loading for Precise Relief of Nonalcoholic Steatohepatitis29
Fluorinated High‐Valent Sn(IV) Porphyrins Show Remarkable Photodynamic Activity in Cancer Cells28
Development of a Brain‐Penetrant Nurr1 Agonist Tool28
Cyclin‐Dependent Kinase 11: Cellular Functions and Potential Therapeutic Applications28
API‐ILs Ionic Adducts: Solubility and Surface Activity Properties—En Route to New Paradigm in Drug Development28
0.55874300003052